Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02662413 · ClinicalTrials.gov registry record
To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 37
- Enrollment target
NCT02662413: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02662413 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02662413 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
To determine the measurement profiles of the asthma control test (ACT) in an adolescent population with persistent asthma.
Primary Outcome
To determine the agreement of the ACT score at the standard cutpoint of \>19 with physician assessment of control using Cohen's kappa.
Interventions
- OTHER Validation of Asthma Control Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-09-27 |
What the finished NCT02662413 record still lists
NCT02662413 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Validation of Asthma Control Questionnaire is the first listed.
NCT02662413 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02662413 about?
NCT02662413 is a clinical study titled "To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma". To determine the measurement profiles of the asthma control test (ACT) in an adolescent population with persistent asthma.
What is the current status of trial NCT02662413?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2016-01. Estimated completion is 2017-09-27.
What interventions are being tested in trial NCT02662413?
The interventions under investigation include: Validation of Asthma Control Questionnaire (OTHER).
Who is sponsoring clinical trial NCT02662413?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia